[artículo]
| Título : |
A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam |
| Tipo de documento: |
texto impreso |
| Autores: |
Usoa E. Busto, Autor ; Howard L. Kaplan, Autor ; C. Eugene Wright, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 628-635 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Afecto, Alprazolam, Ansiolíticos, Bromazepam, Lorazepam, Rendimiento psicomotor. |
| Resumen: |
Sustained-release (SR) alprazolam may facilitate compliance with oral benzodiazepine treatment of panic disorders that currently requires doses administered three or four times daily. To compare the pharmacokinetic, psychomotor performance, and subjective effects of alprazolam SR (1.5 mg), bromazepam (3 mg taken three times daily), and lorazepam (1 mg taken three times daily), 13 male volunteers (aged 20-45 years) randomly received on four separate occasions one of these medications or placebo. |
| Link: |
./index.php?lvl=notice_display&id=31153 |
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 6 (Diciembre) . - pp. 628-635
[artículo] A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam [texto impreso] / Usoa E. Busto, Autor ; Howard L. Kaplan, Autor ; C. Eugene Wright, Autor . - 2023 . - pp. 628-635. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 6 (Diciembre) . - pp. 628-635
| Palabras clave: |
Afecto, Alprazolam, Ansiolíticos, Bromazepam, Lorazepam, Rendimiento psicomotor. |
| Resumen: |
Sustained-release (SR) alprazolam may facilitate compliance with oral benzodiazepine treatment of panic disorders that currently requires doses administered three or four times daily. To compare the pharmacokinetic, psychomotor performance, and subjective effects of alprazolam SR (1.5 mg), bromazepam (3 mg taken three times daily), and lorazepam (1 mg taken three times daily), 13 male volunteers (aged 20-45 years) randomly received on four separate occasions one of these medications or placebo. |
| Link: |
./index.php?lvl=notice_display&id=31153 |
|
A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 6 (Diciembre)
